European Society of Gynaecological Oncology – ESGO shared a post on LinkedIn:
“The Lancet Ovarian Cancer Commission has launched a survey to gather data from both patients and healthcare professionals involved in the care of women with ovarian cancer.
The patient survey seeks to capture lived experiences, unmet needs, preferences, and perceptions of care, while the clinician survey is designed to provide the healthcare perspective on current practices, challenges, and priorities across the ovarian cancer continuum.
The survey findings will create an important evidence base for the Commission’s final recommendations and contribute to shaping future policies, research priorities, and standards of care in ovarian cancer worldwide.
We encourage all clinicians working in ovarian cancer care to participate in this global survey – your perspective and real-world experience is vital for us to gather the evidence needed to garner meaningful change.”
You can also read: Botensilimab Plus Balstilimab Shows 48% Estimated Three-Year Survival in Recurrent Ovarian Cancer at IGCS 2026
